Back to Search Start Over

Exome sequencing identifies frequent mutation of the SWI/SNF complex gene PBRM1 in renal carcinoma

Authors :
Philip J. Stephens
Peter J. Campbell
Claire Hardy
Karl Dykema
Patrick S. Tarpey
Andrew Menzies
Alistair G. Rust
Ville Mustonen
Keiran Raine
Meng-Lay Lin
David A. Largaespada
Stéphane Richard
Dachuan Huang
Juok Cho
David A. Tuveson
Andrej Fischer
Calli Latimer
Helen Davies
John Anema
Richard J. Kahnoski
Stuart McLaren
Bin Tean Teh
Lodewyk F. A. Wessels
David T. Jones
Mingming Jia
Graham R. Bignell
Adam Butler
Laura Mudie
Chutima Subimerb
David J. Adams
Waraporn Chan-on
Jon W. Teague
Gillian L. Dalgliesh
Danushka Galappaththige
Michael R. Stratton
John Marshall
Lucy Stebbings
Ignacio Varela
P. Andrew Futreal
King Wai Lau
Christopher Greenman
Pedro A. Perez-Mancera
Choon Kiat Ong
Kyle A. Furge
Source :
Digital.CSIC. Repositorio Institucional del CSIC, instname, Nature
Publication Year :
2011
Publisher :
Nature Publishing Group, 2011.

Abstract

El pdf del artículo es el manuscrito de autor (PMCID: PMC3030920).-- et al.<br />The genetics of renal cancer is dominated by inactivation of the VHL tumour suppressor gene in clear cell carcinoma (ccRCC), the commonest histological subtype. A recent large-scale screen of ~3,500 genes by PCR-based exon re-sequencing identified several new cancer genes in ccRCC including UTX (also known as KDM6A)1, JARID1C (also known as KDM5C) and SETD2 (ref. 2). These genes encode enzymes that demethylate (UTX, JARID1C) or methylate (SETD2) key lysine residues of histone H3. Modification of the methylation state of these lysine residues of histone H3 regulates chromatin structure and is implicated in transcriptional control3. However, together these mutations are present in fewer than 15% of ccRCC, suggesting the existence of additional, currently unidentified cancer genes. Here, we have sequenced the protein coding exome in a series of primary ccRCC and report the identification of the SWI/SNF chromatin remodelling complex gene PBRM1 (ref. 4) as a second major ccRCC cancer gene, with truncating mutations in 41% (92/227) of cases. These data further elucidate the somatic genetic architecture of ccRCC and emphasize the marked contribution of aberrant chromatin biology.<br />P.A.F. and M.R.S. would like to acknowledge the Wellcome Trust for support under grant reference 077012/Z/05/Z and A. Coffey, D. Turner and L. Mamanova for assistance with the exon capture. K.F., K.D. and B.T.T. acknowledge the support of the Van Andel Research Institute. B.T.T. would like to acknowledge support from the Lee Foundation. I.V. is supported by a fellowship from The International Human Frontier Science Program Organization. D.J.A. acknowledges the support of Cancer Research UK. D.A.T. and P.A.P.-M. acknowledge the support of the University of Cambridge, Cancer Research UK and Hutchison Whampo and thank W. Howatt, A. Hazelhurst and colleagues in the CRI core facilities for their support.

Details

Database :
OpenAIRE
Journal :
Digital.CSIC. Repositorio Institucional del CSIC, instname, Nature
Accession number :
edsair.doi.dedup.....899ec29011a5fd84c659469a6780068d